Press about RVC

NTI Venture Fund Invests 180 Million Rubles in Medical Diagnostics Based on AI

Source: RIA Novosti

© RIA Novosti / Pavel Lisitsyn

The NTI Venture Fund will invest 180 million rubles in the project of a medical diagnostics platform based on artificial intelligence (AI) technology “Celsus”, according to the Russian Venture Company (RVC).

It is noted that the platform is designed to help doctors make decisions in the field of radiology and Oncology. The system recognizes the presence of benign or malignant changes in medical images, indicates their location, and then interprets the results according to international standards. The accuracy of interpretation of the results of the analysis of mammography studies is more than 95%, and fluorography studies is 93%.Currently, finished products for mammography and fluorography have been created, and solutions in the field of morphology and computed tomography, including COVID-19 diagnostics, are at the final stage of development, according to the release.

“The round's investment will be used to grow sales and improve the platform by increasing the types of images and data analyzed, increasing the accuracy of the conclusions and adding new ways to investigate. The company also plans to gain certification in Russia and abroad with a focus on markets in Southeast Asia, the Middle East, Africa and Europe”, the statement said.

“The global market for healthcare solutions, including those affected by the pandemic, has entered a phase of accelerated digital transformation, which has led to the need to find and support promising technology companies developing digital products for medicine. The growth in the volume of medical data, demand for it, as well as changes in industry regulation in the field of implementation of artificial intelligence open a window of opportunity for such projects, and we, as an investor, certainly feel the impact of these market trends. Therefore, we can say that this transaction is not spontaneous, and marked the beginning of the implementation of the Fund's strategy in the field of digital health”, — commented Evgeniy Borisov, a partner of Kama Flow, the managing company of the NTI Venture Fund.

The National Technology Initiative (NTI) Venture Fund was launched by 123 in 2018 with the participation of 123 Infrafund. It is managed by the private investment company Kama Flow and invests in Russian deep tech projects at an early stage. Artificial intelligence, big data analysis and storage technologies, microelectronics, new materials and advanced manufacturing technologies are among the priority fields. The volume of the Fund is 3.5 billion rubles.

Search by name:

Search by date:

Select date in calendar
Select date in calendar